Vitamin D Therapy Market - By Route Of Administration (Oral and Parenteral), By Purchasing Pattern (Prescription Drugs, Over-The-Counter Drugs), By Application (Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders, Skin Diseases, And Other) And By Age Group (Children, Adults, Senior Adults) and By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 189
Status: Published
Report Code: ARI100615
The main use of vitamin D in the body is to bone formation, mineralization, growth, and reduce inflammation. Vitamin D is also useful in the strengthening of the immune system and muscle strength. Vitamin D deficiency means low amount of serum Vitamin D i.e., <75 nmol/L. Vitamin D deficiency leads bone mineralization impairment and leading to the softening of the bones which finally leads to rickets in the children, osteocalcin and osteoporosis in the adults. Main symptoms include increased risk of fractures, depression, back pain, weakness, muscles pains and advancement of cancer etc. The treatment includes mainly vitamin D supplements, dietary food and exposure to sunlight. Vitamin D can be used in any age group because of less side effects. The main side effect associated with vitamin D is overdose and vitamin D can be used for long term under regular supervision of vitamin D levels in the body. Imbalanced diet in the underdeveloped countries and high incidence rate of Vitamin D deficiency in the rest of the globe is main driving force for the vitamin D deficiency treatment market. Vitamin D deficiency is observed in all age groups, due to this there is high need for Vitamin D supplements in the market the manifestations due to vitamin D deficiency is ranging from bone disorder to cancer and this makes healthcare facilities and government agencies to put more focus towards vitamin D deficiencies. Natural availability of Vitamin D is less and this leads to the inclination towards vitamin D supplements. Other implications like obesity and sedentary life style are also driving vitamin D deficiency treatment market to control the disorders. Geographical area is also one of the reasons for the vitamin D deficiency where sun light exposure is less. Increased geriatric population and consumer awareness regarding vitamin D deficiency implications leading towards more growth in vitamin D deficiency treatment market.
Less availability of vitamin D therapies in the underdeveloped countries leads low growth rate in the vitamin D deficiency treatment market. Government policies also act as a constraint in the growth of vitamin D deficiency market due to the toxicity of the high doses of the vitamin D.
Some of the prominent players in the market are Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd (India).
Abbott (US) is the largest player in the vitamin D therapy market. It has a strong foothold in the market. Abbott has a global distribution network and a good brand reputation among end users. The company’s strong presence and wide distribution channels across the globe have helped it to maintain its leading position in the market. In order to strengthen its position in the market, the company significantly invests in R&D activities. In 2018, the company invested USD 2.30 billion in R&D activities as compared to USD 2.26 billion in 2017
Analyst Commentary
Vitamin D deficiency treatment market is growing at high pace. The global Vitamin D deficiency market is highly fragmented with national and international companies. Over the counter market owes major market share when compared to the others. In recent time expenditure on R&D of vitamin D deficiency treatment is increasing because increased number of deficiency cases over the globe. New formulation for vitamin D deficiency treatment is increased from past few decades and also expected new launch in upcoming years is more. To improve the quality of life of individuals, governments are implementing new policies which act as a best driving force for development of vitamin D deficiency treatment market.
By route of administration, the oral route of administration is expected to register the largest share and highest CAGR during the forecast period. This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route.
Based on application, the osteoporosis segment is expected to register the highest growth during the forecast period. This growth can be attributed to the increasing incidence of falls and fractures in senior adults due to the elevated levels of parathyroid hormones and the poor absorption of calcium from their diets.
Segmentation
The global vitamin D therapy market is segmented on the basis of route of administration, purchasing pattern, and application and age group. Based on route of administration, the market is segmented as oral and parenteral. On the basis of purchasing pattern the market is segmented into prescription drugs, over-the-counter drugs. On the basis of application, the market is segmented into osteoporosis, rickets, muscle weakness, autoimmune disorders, skin diseases, and other applications. On the basis of age group, the market is segmented into Children, Adults, Senior Adults.
Regional Analysis
North America is expected to dominate the overall vitamin D therapy market throughout the forecast period. This dominance is mainly owing to the presence of leading players based in the United States, focus on research activities to develop more patient compliant products with enhanced efficiency coupled by the government support and increasing healthcare expenditure contributing to its outstanding market revenue share in the global vitamin D therapy market growth.
The Asia Pacific market is also anticipated to witness the highest CAGR in the overall vitamin D therapy market during the forecast period. The significant growth in the region can be attributed to sedentary lifestyles, huge target patient pool due to heavy population in developing nations like India, China, and along with higher air pollution. Also, a rise in awareness programs about vitamin D deficiency by the government and manufacturers of emerging economies in the region is expected to boost the growth of the market propelling the global market revenue.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Vitamin D Therapy Market
Chapter 5. Global Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
5.1. Global Vitamin D Therapy Market Share, By Route of Administration, 2015 - 2027 (USD Million)
5.1.1. Oral
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Parental
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(USD Million)
6.1. Global Vitamin D Therapy Market Share, By Purchasing Pattern, 2015 - 2027 (USD Million)
6.1.1. Prescription Drugs
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Over-the-counter Drugs
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Vitamin D Therapy Market Overview, By Age group, 2015 - 2027(USD Million)
7.1. Global Vitamin D Therapy Market Share, By Age group, 2015 - 2027 (USD Million)
7.1.1. Children
7.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Adults
7.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
7.1.3. Senior Adults
7.1.3.1. Market Type and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Vitamin D Therapy Market Overview, By Application, 2015 - 2027(USD Million)
8.1. Global Vitamin D Therapy Market Share, By Application, 2015 - 2027 (USD Million)
8.1.1. Osteoporosis
8.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
8.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
8.1.2. Rickets
8.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
8.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
8.1.3. Muscle weakness
8.1.3.1. Market Type and Projections, 2015 - 2027 (USD Million)
8.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
8.1.4. Autoimmune disorders
8.1.4.1. Market Type and Projections, 2015 - 2027 (USD Million)
8.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
8.1.5. Skin diseases
8.1.5.1. Market Type and Projections, 2015 - 2027 (USD Million)
8.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
8.1.6. Others
8.1.6.1. Market Type and Projections, 2015 - 2027 (USD Million)
8.1.6.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 9. Global Vitamin D Therapy Market Overview, By Geography, 2015 - 2027(USD Million)
9.1. Global Vitamin D Therapy Market Share, By Geography, 2015 - 2027(USD Million)
9.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Million)
9.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 10. North America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. North America Vitamin D Therapy Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.2. North America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
10.1.3. North America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
10.1.4. North America Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (USD Million)
10.1.5. North America Vitamin D Therapy Market Overview, By Application,2015 - 2027 (USD Million)
10.1.6. North America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.6.1. U.S. Vitamin D Therapy Market Overview, 2015 - 2027 (USD Million)
10.1.6.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.6.1.2. U.S. Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
10.1.6.1.3. U.S. Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
10.1.6.1.4. Other Segment
10.1.6.2. Canada Vitamin D Therapy Market Overview, 2015 - 2027 (USD Million)
10.1.6.2.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.6.2.2. Canada Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
10.1.6.2.3. Canada Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
10.1.6.2.4. Other Segment
10.1.6.3. Mexico Vitamin D Therapy Market Overview, 2015 - 2027 (USD Million)
10.1.6.3.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.6.3.2. Mexico Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
10.1.6.3.3. Mexico Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
10.1.6.3.4. Other Segment
Chapter 11. Europe Vitamin D Therapy Market Overview, By Countries, 2015 - 2027(USD Million)
11.1. Europe Vitamin D Therapy Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.2. Europe Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
11.1.3. Europe Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
11.1.4. Europe Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (USD Million)
11.1.5. Europe Vitamin D Therapy Market Overview, By Application,2015 - 2027 (USD Million)
11.1.6. Europe Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.6.1. Germany
11.1.6.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.6.1.2. Germany Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
11.1.6.1.3. Germany Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(USD Million)
11.1.6.1.4. Other Segments
11.1.6.2. France
11.1.6.2.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.6.2.2. France Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
11.1.6.2.3. France Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(USD Million)
11.1.6.2.4. Other Segments
11.1.6.3. UK
11.1.6.3.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.6.3.2. UK Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
11.1.6.3.3. UK Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(USD Million)
11.1.6.3.4. Other Segments
11.1.6.4. Italy
11.1.6.4.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.6.4.2. Italy Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
11.1.6.4.3. Italy Vitamin D Therapy Market Overview, By Purchasing Pattern2015 - 2027(USD Million)
11.1.6.4.4. Other Segments
11.1.6.5. Spain
11.1.6.5.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.6.5.2. Spain Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
11.1.6.5.3. Spain Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(USD Million)
11.1.6.5.4. Other Segments
11.1.6.6. Rest of Europe
11.1.6.6.1. Market Type and projections, 2015 – 2027
11.1.6.6.2. Rest of Europe Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
11.1.6.6.3. Rest of Europe Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(USD Million)
11.1.6.6.4. Other Segments
Chapter 12. Asia Pacific Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Asia Pacific Vitamin D Therapy Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.2. Asia Pacific Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
12.1.3. Asia Pacific Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
12.1.4. Asia Pacific Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (USD Million)
12.1.5. Asia Pacific Vitamin D Therapy Market Overview, By Application,2015 - 2027 (USD Million)
12.1.6. Asia Pacific Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.6.1. India
12.1.6.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.6.1.2. India Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
12.1.6.1.3. India Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
12.1.6.1.4. Other Segments
12.1.6.2. China
12.1.6.2.1. Market Type and projections, 2015 - 2027(USD Million)
12.1.6.2.2. China Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
12.1.6.2.3. China Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
12.1.6.2.4. Other Segments
12.1.6.3. Japan
12.1.6.3.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.6.3.2. Japan Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
12.1.6.3.3. Japan Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(USD Million)
12.1.6.3.4. Other Segments
12.1.6.4. South Korea
12.1.6.4.1. Market Type and projections, 2015 - 2027(USD Million)
12.1.6.4.2. South Korea Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
12.1.6.4.3. South Korea Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
12.1.6.4.4. Other Segments
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.6.5.2. Rest of Asia Pacific Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(USD Million)
12.1.6.5.3. Rest of Asia Pacific Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
12.1.6.5.4. Other Segments
Chapter 13. Middle East & Africa Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. Middle East & Africa Vitamin D Therapy Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.2. Middle East & Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
13.1.3. Middle East & Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
13.1.4. Middle East & Africa Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (USD Million)
13.1.5. Middle East & Africa Vitamin D Therapy Market Overview, By Application,2015 - 2027 (USD Million)
13.1.6. Middle East & Africa Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1.6.1. GCC
13.1.6.1.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.6.1.2. GCC Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
13.1.6.1.3. GCC Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
13.1.6.1.4. Other Segments
13.1.6.2. South Africa
13.1.6.2.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.6.2.2. South Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
13.1.6.2.3. South Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
13.1.6.2.4. Other Segments
13.1.6.3. Rest of Middle East & Africa
13.1.6.3.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.6.3.2. Rest of Middle East & Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
13.1.6.3.3. Rest of Middle East & Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
13.1.6.3.4. Other Segments
Chapter 14. South America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (USD Million)
14.1. South America Vitamin D Therapy Market Overview, 2015 - 2027 (USD Million)
14.1.1. Market Type and projections, 2015 - 2027 (USD Million)
14.1.2. South America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
14.1.3. South America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
14.1.4. South America Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (USD Million)
14.1.5. South America Vitamin D Therapy Market Overview, By Application,2015 - 2027 (USD Million)
14.1.6. South America Vitamin D Therapy Market Overview, By Countries, 2015- 2026 (USD Million)
14.1.7. Brazil
14.1.7.1. Market Type and projections, 2015 - 2027 (USD Million)
14.1.7.2. Brazil Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
14.1.7.3. Brazil Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
14.1.7.4. Other Segments
14.1.8. Argentina
14.1.8.1. Market Type and projections, 2015 - 2027 (USD Million)
14.1.8.2. Argentina Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
14.1.8.3. Argentina Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
14.1.8.4. Other Segments
14.1.9. Rest of South America
14.1.9.1. Market Type and projections, 2015 – 2027
14.1.9.2. Rest of South America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (USD Million)
14.1.9.3. Rest of South America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (USD Million)
14.1.9.4. Other Segments
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2020
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New Technology development
Chapter 16. Key Vendor Analysis
16.1. Sanofi
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Mice Benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. GlaxoSmithKline plc
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Mice Benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. Pfizer Inc
16.3.1. Company overview
16.3.2. Financial performance
16.3.3. Mice Benchmarking
16.3.4. Recent initiatives
16.4. Merck & Co., Inc
16.5. Torrent Pharmaceuticals
16.6. Novartis International AG
16.7. Alkem Laboratories
16.8. Sun Pharmaceuticals Industries Ltd.
16.9. Cadila Healthcare Ltd.
16.10. Others
Chapter 17. Vitamin D Therapy Market Cost Analysis
17.1. Vitamin D Therapy Market Key Technology Analysis
17.1.1. Key Technology
17.1.2. Price Trend of Key Technology
17.1.3. Key Suppliers of Technology
17.1.4. Market Concentration Rate of Technology
17.1.5. Technology
17.1.6. Labor Cost
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. Vitamin D Therapy Market Industrial Chain Analysis
18.2. Upstream Technology Sourcing
18.3. Technology Sources of Vitamin D Therapy Market Major Manufacturers in 2021
18.4. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Technology Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Technology Progress in Related Type
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Vitamin D Therapy Market share, By Route of Administration, 2020 & 2027 (%)
10. Global Vitamin D Therapy Market share, by Oral, By Route of Administration, 2015 - 2027 (USD Million)
11. Global Vitamin D Therapy Market share, by Parental, By Route of Administration, 2015 - 2027 (USD Million)
12. Global Vitamin D Therapy Market share, By Purchasing Pattern, 2020 & 2027 (%)
13. Global Vitamin D Therapy Market share, by Prescription Drugs, By Purchasing Pattern, 2015 - 2027 (USD Million)
14. Global Vitamin D Therapy Market share, by Over-the-counter Drugs, By Purchasing Pattern 2015 - 2027 (USD Million)
15. Global Vitamin D Therapy Market share, By Age group, 2020 & 2027 (%)
16. Global Vitamin D Therapy Market share, by Children, By Age group, 2015 - 2027 (USD Million)
17. Global Vitamin D Therapy Market share, by Adults, By Age group 2015 - 2027 (USD Million)
18. Global Vitamin D Therapy Market share, by Senior Adults, By Age group 2015 - 2027 (USD Million)
19. Global Vitamin D Therapy Market Overview, By Application, 2020 & 2027 (%)
20. Global Vitamin D Therapy Market share, by Osteoporosis, By Application 2015 - 2027 (USD Million)
21. Global Vitamin D Therapy Market share, by Rickets, By Application 2015 - 2027 (USD Million)
22. Global Vitamin D Therapy Market share, by Muscle weakness, By Application 2015 - 2027 (USD Million)
23. Global Vitamin D Therapy Market share, by Autoimmune disorders, By Application 2015 - 2027 (USD Million)
24. Global Vitamin D Therapy Market share, by Skin diseases, By Application 2015 - 2027 (USD Million)
25. Global Vitamin D Therapy Market share, by Others, By Application 2015 - 2027 (USD Million)
26. Global Vitamin D Therapy Market share, by region, 2020 & 2027 (%)
27. Global Vitamin D Therapy Market share, by region, 2015 - 2027(USD Million)
28. North America Vitamin D Therapy Market, 2015 - 2027(USD Million)
29. North America Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
30. U.S. Vitamin D Therapy Market, 2015 - 2027(USD Million)
31. Canada Vitamin D Therapy Market, 2015 - 2027(USD Million)
32. Mexico Vitamin D Therapy Market, 2015 - 2027(USD Million)
33. Europe Vitamin D Therapy Market, 2015 - 2027(USD Million)
34. Europe Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
35. Spain Vitamin D Therapy Market, 2015 - 2027(USD Million)
36. UK Vitamin D Therapy Market, 2015 - 2027(USD Million)
37. Italy Vitamin D Therapy Market, 2015 - 2027(USD Million)
38. Germany Vitamin D Therapy Market, 2015 - 2027(USD Million)
39. France Vitamin D Therapy Market, 2015 - 2027(USD Million)
40. Rest of Europe Vitamin D Therapy Market, 2015 - 2027(USD Million)
41. Asia-Pacific Vitamin D Therapy Market, 2015 - 2027(USD Million)
42. Asia-Pacific Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
43. China Vitamin D Therapy Market, 2015 - 2027(USD Million)
44. India Vitamin D Therapy Market, 2015 - 2027(USD Million)
45. Australia Vitamin D Therapy Market, 2015 - 2027(USD Million)
46. Japan Vitamin D Therapy Market, 2015 - 2027(USD Million)
47. Rest of Asia-Pacific Vitamin D Therapy Market, 2015 - 2027(USD Million)
48. Middle East & Africa Vitamin D Therapy Market, 2015 - 2027(USD Million)
49. Middle East & Africa Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
50. GCC Vitamin D Therapy Market, 2015 - 2027(USD Million)
51. South Africa Vitamin D Therapy Market, 2015 - 2027(USD Million)
52. Rest Of Middle East & Africa Vitamin D Therapy Market, 2015 - 2027(USD Million)
53. South America Vitamin D Therapy Market, 2015 - 2027(USD Million)
54. Brazil Vitamin D Therapy Market, 2015 - 2027(USD Million)
55. Mexico Vitamin D Therapy Market, 2015 - 2027(USD Million)
56. Argentina Vitamin D Therapy Market, 2015 - 2027(USD Million)
57. Rest Of South America Vitamin D Therapy Market, 2015 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Vitamin D Therapy Market, 2015-2027 (USD Million)
4. Vitamin D Therapy requirement, by country, 2015-2027, (USD Million)
5. North America Vitamin D Therapy Market, By Route of Administration, 2015-2027 (USD Million)
6. North America Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (USD Million)
7. North America Vitamin D Therapy Market, By Age group, 2015-2027 (USD Million)
8. North America Vitamin D Therapy Market, By Application, 2015-2027 (USD Million)
9. Europe Vitamin D Therapy Market, By Route of Administration, 2015-2027 (USD Million)
10. Europe Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (USD Million)
11. Europe Vitamin D Therapy Market, By Age group, 2015-2027 (USD Million)
12. Europe Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (USD Million)
13. Europe Vitamin D Therapy Market, By Application, 2015-2027 (USD Million)
14. Asia Pacific Vitamin D Therapy Market, By Route of Administration, 2015-2027 (USD Million)
15. Asia Pacific Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Revenue, USD Million)
16. Asia Pacific Vitamin D Therapy Market, By Age group, 2015-2027 (Revenue, USD Million)
17. Asia Pacific Vitamin D Therapy Market, By Application, 2015-2027 (Revenue, USD Million)
18. Middle East & Africa Vitamin D Therapy Market, By Route of Administration, 2015-2027 (USD Million)
19. Middle East & Africa Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (USD Million)
20. Middle East & Africa Vitamin D Therapy Market, By Age group, 2015-2027 (USD Million)
21. Middle East & Africa Vitamin D Therapy Market, By Application, 2015-2027 (USD Million)
22. South America Vitamin D Therapy Market, By Route of Administration, 2015-2027 (USD Million)
23. South America Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (USD Million)
24. South America Vitamin D Therapy Market, By Age group, 2015-2027 (USD Million)
25. South America Vitamin D Therapy Market, By Application, 2015-2027 (USD Million)
26. Global Vitamin D Therapy Market, Company Market Share, 2020 - 2027 (%)
27. Sanofi: Product Benchmarking
28. Sanofi: Financial Performance
29. GlaxoSmithKline plc: Product Benchmarking
30. GlaxoSmithKline plc: Financial Performance
31. Pfizer Inc. : Product Benchmarking
32. Pfizer Inc. : Financial Performance
33. Merck & Co., Inc. : Product Benchmarking
34. Merck & Co., Inc. : Financial Performance
35. Torrent Pharmaceuticals: Product Benchmarking
36. Torrent Pharmaceuticals: Financial Performance
37. Novartis International AG: Product Benchmarking
38. Novartis International AG: Financial Performance
39. Alkem Laboratories: Product Benchmarking
40. Alkem Laboratories: Financial Performance
41. Sun Pharmaceuticals Industries Ltd.: Product Benchmarking
42. Sun Pharmaceuticals Industries Ltd.: Financial
43. Cadila Healthcare Ltd.: Product Benchmarking
44. Cadila Healthcare Ltd.: Financial Performance
The Leading Key Players in Vitamin D Therapy Market
Abbott (US)
Sanofi (France)
GlaxoSmithKline plc (UK)
Pfizer Inc. (US)
Merck & Co. Inc. (US)
Torrent Pharmaceuticals Ltd. (India)
Novartis International AG (Switzerland)
Alkem Laboratories (India)
Sun Pharmaceutical Industries Ltd. (India)
Cadila Healthcare Ltd (India).
